Philippine’s vaccine mix-and-match study awaits FDA nodFrontliners get inoculated with Aztrazeneca COVID-19 vaccine during the continuation of vaccination for health workers and frontliners at Marikina Sports Complex on March 24, 2021. MANILA, Philippines — Filipino scientists are raring to begin a state-funded initiative to study the “mix-and-match” of a variety of vaccines being administered in the country’s mass immunization against COVID-19. Earlier, DOST said the study presupposes China-made Sinovac as the first dose since it is the vaccine which the country has the most stable supply in storage. For Group B, the vaccines to be combined after the first Sinovac dose are the other vaccines that have already been given an emergency use authorization (EUA) by the FDA. The vaccine mix-and-match trial will not include people under 17 years old.

Source: Philippine Star October 23, 2021 19:19 UTC